Thinking Porphyria, Working Together

International Congress on
Porphyrins and Porphyrias

4-7 September 2022
Sofia, Bulgaria

Аbstract submission still open!
(Extended until July 10th , 2022) Submit
Toggle Bar

Section Chairs

Sverre Sandberg
Sverre Sandberg

Sverre Sandberg

Professor Sverre Sandberg MD, PhD is director of the Norwegian Quality Improvement of Laboratory examinations (NOKLUS) and the Norwegian Porphyria Center (NAPOS). He has been president of the European Organization for External Quality Assurance Providers in Laboratory Medicine (EQALM), president of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and has been a board member of IFCC. He is currently the president of the European Porphyria Network association (EPNET), chair of the council of ICHCLR and chair of the Task Group in EFLM for the Biological Variation Database. He also participates in other WGs in EFLM and IFCC.  His professional interests are in porphyria, evidence-based laboratory medicine, quality improvement of point of care instruments, biological variation, analytical performance specifications.

Peter Meissner
Peter Meissner

Peter Meissner

Peter Meissner has been associated with the University of Cape Town (UCT) Porphyria Laboratories at Groote Schuur Hospital since his student days, and his research career has focused on the porphyrias since 1982. As a medical biochemist his studies have centered primarily on the enzymes of the haem pathway, the biochemical and molecular (and clinical) mechanisms related to the pathogenesis and diagnosis of the porphyrias and spin-off projects associated with running the major specialist porphyria Centre in South Africa. He has maintained a close relationship with the University of Georgia where he spent time in the Dailey lab as a visiting Postdoc in the early 90’s.

In 2008 he was awarded the Chair in Medical Biochemistry at UCT, where he is now Professor (and previous Head). His current substantive role at UCT is as Director of Postgraduate Studies and Researcher Development, a senior leadership position born out of his passion and interest in training postgraduate students and developing young researchers across the university.

Amy Medlock
Amy Medlock

Amy Medlock

Dr. Medlock received her BS in Chemistry from Erskine College and PhD in Biochemistry and Molecular Biology from the University of Georgia, and she completed a postdoctoral fellowship at the University of Cape Town. She is currently an Associate Professor at the University of Georgia and the Augusta University/University of Georgia Medical Partnership. Work in her laboratory focuses on heme biosynthesis and its regulation via protein complexes in the mitochondria. This work will lead to a better understanding of cellular and total body heme homeostasis and the development of effective treatments for diseases including anemias, porphyrias, cancers and infectious diseases.

Laurent Gouya
Laurent Gouya

Laurent Gouya

Professor of Genetics University of Paris
Head Centre de Reference Maladies Rares Porphyries, Paris
Head INSERM UMR-S 1149, Team Heme and iron metabolism, Paris

Bruce Wang
Bruce Wang

Bruce Wang

Bruce Wang is an assistant professor in the division of gastroenterology and department of medicine at the University of California San Francisco. He runs the UCSF Porphyria Center and is a principal investigator in the US Porphyrias Consortium. He has a particular focus on improving the clinical diagnosis of porphyrias and evaluating drug safety in acute hepatic porphyrias. In addition to porphyria research, he also runs a research laboratory studying liver biology.

Petro Petrides

Germany

Jean-Charles Deybach
Jean-Charles Deybach

Jean-Charles Deybach

Jean-Charles DEYBACH, MD, PhD, Professor of Biochemistry and Molecular Genetics at the Faculty of Medicine, University Denis Diderot Paris 7, France.

  • Previous Head of the Department of Biochemistry and Molecular Genetics at Louis Mourier Hospital (APHP) and president of the French Reference Center for Porphyrias (CFP). Honorary president of the CFP since his retirement in 2017
  • 35 years experience on research in heme biosynthesis and human porphyrias
  • He launched in 2001 the European Porphyria Initative (EPI) to built a dedicated porphyria network in Europe. Funded as a pilot project by EU Commission he became from 2007until 2013 the President and main coordinator of the European Reference Porphyria Network (EPNET) which links porphyria reference center from EU and non EU countries. Since 2018 honorary member of the EPNET association.

Maria Cappellini

Italy

Karl Anderson
Karl Anderson

Karl E. Anderson

Dr. Anderson is a graduate of the Johns Hopkins University School of Medicine, completed residency in internal medicine at Vanderbilt University Hospital and the New York Hospital-Cornell Medical Center, followed by training in gastroenterology also at Cornell. He was a member of the faculty at the Rockefeller University, Cornell University Medical College and New York Medical College before coming to the University of Texas Medical Branch at Galveston in 1987, where he is a Professor in the Department of Internal Medicine (Division of Gastroenterology and Hepatology).  He directs the Porphyria Laboratory and Center at UTMB, which is part of the NIH-supported Porphyrias Consortium.  He is an active clinical investigator with support from the NIH, FDA, foundations and industry.  His research focusses on the human porphyrias and their treatment. 

Mike Badminton
Mike Badminton

Mike Badminton

Mike Badminton was Clinical Lead for the National Acute Porphyria Service Cardiff centre, and Director of the Cardiff SAS Porphyria Service laboratories until retiring at the end of 2021.

He has been involved in the diagnosis and management of all types of porphyria since 2001 and his research interests include the erythropoietic porphyrias, and more recently identifying modifier genes in acute porphyria.

He is a founder member of the European Porphyria Network, which was established to improve healthcare for porphyria patients and their families. He is involved in a number of international collaborative projects aimed at supporting other clinicians diagnosing and managing porphyria through sharing diagnostic information and developing consensus guidelines.  

Herbert Bonkovsky
Herbert Bonkovsky

Herbert L. Bonkovsky

Herbert L. Bonkovsky, M.D., is a tenured Professor of Medicine and MolecularHerbert L. Bonkovsky, M.D., is a tenured Professor of Medicine and Molecular Medicine & Translational Science and Director of The Liver and Metabolic Disorders Laboratory at Atrium-Wake Forest University/NC Baptist Medical Center, Winston-Salem, NC. Dr. Bonkovsky also has academic appointments as Visiting Professor at Winston-Salem State University, Professor of Medicine at The University of CT Health Center, and Professor of Biology and Medicine at the University of North Carolina. Dr. Bonkovsky is known nationally and internationally as a clinical hepatologist, teacher, mentor, and clinical investigator. He is a valedictory graduate of Earlham College [Richmond, IN] and Case Western Reserve University School of Medicine [Cleveland, OH]. His Post-graduate training was at Duke University, Case Western Reserve University School of Medicine, The U.S. National Institutes of Health, Dartmouth Medical School, and Yale University.

ICPP 2022

ICPP 2022

Thinking Porphyria, Working Together

International Congress on
Porphyrins and Porphyrias

4-7 September 2022
Sofia, Bulgaria

ICPP 2022

ICPP 2022

Thinking Porphyria, Working Together

International Congress on
Porphyrins and Porphyrias

4-7 September 2022
Sofia, Bulgaria

© Copyright 2020 Sofia. All Rights Reserved.